Shares of Acura Pharmaceuticals (ACUR) had a solid day today, finishing up over 18% after the company said Pfizer (PFE) will expand commercialization of Oxecta Tablets to health care providers in Q4. These campaign will be directed towards a national cross section of healthcare professionals who treat pain, but will not include the use of field representatives. ACUR receives tiered royalties ranging from 5% to 25% on net sales the pain killer.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs